Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0006 (4.17%)
Aug 1, 2025, 2:10 PM EDT
Accolade Market Cap
Emmaus Life Sciences has a market cap or net worth of $957.98 thousand as of August 1, 2025. Its market cap has decreased by -83.76% in one year.
Market Cap
957.98K
Enterprise Value
32.60M
Revenue
16.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 957.98K, a decrease of -99.73%. That is a compound annual growth rate of -62.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 957.98K | 76.47% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | 60.25M | -36.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |